Oral pill improves care of patients with bone marrow cancer: Study
Momelotinib, an oral pill taken once a day, significantly improved outcomes of patients treated for myelofibrosis (MF), a rare but fatal bone marrow cancer, researchers reported June 7. Ruben Mesa, MD, FACP, executive director ...
Jun 7, 2022
0
3